Geode Capital Management LLC Buys 25,054 Shares of Sotera Health (NASDAQ:SHC)

Geode Capital Management LLC grew its position in Sotera Health (NASDAQ:SHC - Free Report) by 0.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,780,445 shares of the company's stock after buying an additional 25,054 shares during the period. Geode Capital Management LLC owned 0.98% of Sotera Health worth $38,048,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Barclays PLC raised its holdings in Sotera Health by 169.8% during the 3rd quarter. Barclays PLC now owns 473,597 shares of the company's stock worth $7,909,000 after purchasing an additional 298,085 shares during the last quarter. KBC Group NV lifted its holdings in Sotera Health by 4,094.6% in the fourth quarter. KBC Group NV now owns 186,365 shares of the company's stock valued at $2,549,000 after buying an additional 181,922 shares during the period. SG Americas Securities LLC grew its holdings in Sotera Health by 271.6% during the 4th quarter. SG Americas Securities LLC now owns 36,364 shares of the company's stock worth $497,000 after acquiring an additional 26,577 shares during the period. Envestnet Portfolio Solutions Inc. raised its position in shares of Sotera Health by 17.3% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 15,839 shares of the company's stock valued at $217,000 after acquiring an additional 2,340 shares during the last quarter. Finally, State Street Corp lifted its stake in shares of Sotera Health by 18.5% in the 3rd quarter. State Street Corp now owns 4,126,806 shares of the company's stock valued at $68,918,000 after purchasing an additional 644,236 shares during the period. Institutional investors and hedge funds own 91.03% of the company's stock.

Sotera Health Trading Down 0.1 %

Sotera Health stock traded down $0.01 during mid-day trading on Friday, hitting $10.48. 858,965 shares of the company's stock were exchanged, compared to its average volume of 1,202,288. Sotera Health has a fifty-two week low of $9.53 and a fifty-two week high of $17.08. The company's 50 day simple moving average is $11.82 and its 200-day simple moving average is $13.30. The firm has a market capitalization of $2.97 billion, a P/E ratio of 41.92 and a beta of 1.88. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91.

Wall Street Analyst Weigh In

Separately, Barclays dropped their price objective on Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $15.20.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.